ChrysCapital acquires controlling stake in Novartis India
ChrysCapital acquires controlling stake in Novartis India; Vikas Gupta named MD & CEO. The deal marks a major shift in ownership, with ChrysCapital now in control. Vikas Gupta has been appointed as the new MD & CEO, signaling strategic leadership change. This acquisition reflects strong investor confidence in the Indian pharma sector.
📊 STOCKS: $NOVARTISINDIA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.